SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vineet Laboratories Ltd (VINEETLAB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543298 NSE: VINEETLAB Pharmaceuticals & Drugs | Small Cap | Vineet Laboratories Share Price

₹33.61 -1.66 (-4.71%)

As on 04-Jun'26 16:59

Vineet Laboratories Ltd (VINEETLAB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543298 NSE: VINEETLAB Pharmaceuticals & Drugs | Small Cap | Vineet Laboratories Share Price

₹33.61 -1.66 (-4.71%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹65 Cr.
Current Price
₹33.6
52-Week Low / High
₹24 / 44
TTM EPS
₹-5.3
TTM Sales
₹54.6 Cr.
Book Value per Share
₹23.5
P/E Ratio
0.00
Lower than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
1.43
Lower than its 5-year historical median
Price to Sales (P/S)
1.18
Higher than its 5-year historical median
EV/EBITDA
-29.58
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
-81.79%
Underperforms industry median
Return on Capital Employed (ROCE)
-25.12%
Underperforms industry median
Return on Assets (ROA)
-19.10%
Operating Profit Margin
-21.7%
Net Profit Margin
-26.92%
Gross Profit Margin
-24.4%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-50.2%
Operating Profit Growth (1 Year)
-
-326.11%
Net Profit Growth (1 Year)
-
-2060.19%
Asset Quality
Promoter Holding
5.98%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹26 Cr.
Equity
₹19.2 Cr.
Face Value
₹10
All Time Low / High
₹21.30 / 104.78

Vineet Laboratories stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Vineet Laboratories Ltd a good quality company?
Vineet Laboratories Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Vineet Laboratories Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Vineet Laboratories Ltd vs industry peers?
Vineet Laboratories Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Vineet Laboratories Ltd?
Promoters hold 5.98% of the Vineet Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Vineet Laboratories Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -4.56% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vineet Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%-2.9%34.1%23.1%8.7%7.2%-25.1%-
Value Creation
Index
NANA-1.21.40.7-0.4-0.5-2.8-

Growth Parameters

Sales 0002431912121517555
Sales YoY Gr.-NANANA-21.5%11.1%-29.1%-50.2%-
Adj EPS 00-0.21.561.40.9-18.4-5.3
YoY Gr.-NANANA313.1%-77.3%-31.6%-2079.6%-
BVPS (₹) -3.37.78.224.330.330.731.713.423.5
Adj Net
Profit
00-01.66.61.51-20.2-10
Cash Flow from Ops. 00-027.57.6-9.6-6.611.5-
Debt/CF from Ops. 0000.53.5-3.2-6.73.5-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA-26.8%-50.2%
Adj EPS NANA-245.4%-2079.6%
BVPSNA10.3%-23.9%-57.8%
Share Price - - -7.6% 24.5%

Key Financial Parameters

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
00-2.811.8224.53-81.8-28.7
Op. Profit
Mgn %
0003.46.93.84.8-21.7-9.3
Net Profit
Mgn %
0000.73.40.70.7-26.9-18.6
Debt to
Equity
0000.50.80.91.32.7-
Working Cap
Days
00065172156215383379
Cash Conv.
Cycle
000183251109216-34

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales000243.48191.17212.29150.5975
Operating Expenses + 000.01235.33178.01204.63143.3991.28
Manufacturing Costs00026.5218.8318.2816.2510.97
Material Costs000198.11145.55172.33113.9270.24
Employee Cost 0005.574.9166.385.34
Other Costs 000.015.138.738.036.844.73
Operating Profit 00-0.018.1513.167.667.20-16.28
Operating Profit Margin (%) ---3.3%6.9%3.6%4.8%-21.7%
Other Income + 0000.390.290.120.461.99
Exceptional Items 00000000
Interest 0002.672.093.384.783.98
Depreciation 0001.812.022.372.522.50
Profit Before Tax 00-0.014.069.352.030.36-20.78
Tax 0002.282.710.78-0.66-0.58
Profit After Tax 00-0.011.786.641.251.03-20.19
PAT Margin (%) ---0.7%3.5%0.6%0.7%-26.9%
Adjusted EPS (₹)0.00.0-0.21.66.11.10.9-18.4
Dividend Payout Ratio (%)0%0%0%0%13.90%0%0%0%

Valuation of Vineet Laboratories - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 0.010.410.4026.6233.2233.6834.7214.65
Share Capital 0.010.410.419.229.229.229.229.22
Reserves 00-0.0117.402424.4625.515.43
Debt +00012.4726.5130.0542.9839.06
Long Term Debt0003.471.724.853.893.79
Short Term Debt0009.0124.7925.2039.0935.28
Minority Interest00000000
Trade Payables0.010.01055.9960.0934.8932.2633.61
Others Liabilities 0.010013.6713.4917.236.917.22
Total Liabilities 0.020.420.40108.74133.32115.85116.8794.54

Fixed Assets

Net Fixed Assets +00019.6721.3826.6526.9225.46
Gross Block00035.4839.2246.8549.6450.69
Accumulated Depreciation00015.8217.8320.2122.7325.23
CWIP 00000000
Investments 0000.120.140.130.180.21
Inventories00039.6943.5446.1749.3949.97
Trade Receivables00042.7136.2035.1631.6013.25
Cash Equivalents 00.0102.1018.120.950.440.67
Others Assets 0.020.410.404.4613.946.798.344.99
Total Assets 0.020.420.40108.74133.32115.85116.8794.54

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 00-027.497.63-9.62-6.6111.49
PBT 00-0.014.069.352.030.36-20.78
Adjustment 0005.713.905.976.788.44
Changes in Working Capital 000.0116.87-2.43-14.63-13.523.95
Tax Paid 0000.85-3.18-2.99-0.25-0.12
Cash Flow From Investing Activity + 000-7.81-3.68-6.69-2.22-3.18
Capex 000-7.850-7.63-2.79-1.05
Net Investments 0000-3.84000
Others 0000.050.160.950.57-2.14
Cash Flow From Financing Activity + 00018.6211.960.278.43-8.23
Net Proceeds from Shares 0008.810000
Net Proceeds from Borrowing 000014.044.17-0.69-0.43
Interest Paid 000-2.67-2.09-3.38-4.78-3.98
Dividend Paid 00000-0.9200
Others 00012.4700.4113.90-3.82
Net Cash Flow 00-038.3015.91-16.03-0.400.08

Financial Ratio

PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)00-2.8713.1822.193.743-81.79
ROCE (%)00-2.8734.0623.148.697.16-25.12
Asset Turnover Ratio0004.461.581.71.290.71
PAT to CFO Conversion(x)N/AN/AN/A15.441.15-7.7-6.42N/A
Working Capital Days
Receivable Days0006475.3061.4080.90109.10
Inventory Days00059.5079.5077.10115.80241.80
Payable Days00051.60145.60100.60107.60171.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vineet Laboratories Ltd FAQs

The current trading price of Vineet Laboratories on 04-Jun-2026 16:59 is ₹33.61.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Vineet Laboratories stood at ₹64.55 Cr

The latest P/E ratio of Vineet Laboratories as of 03-Jun-2026 is 0.00.

The latest P/B ratio of Vineet Laboratories as of 03-Jun-2026 is 1.43.

The 52-week high of Vineet Laboratories is ₹43.56 and the 52-week low is ₹23.82.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vineet Laboratories is ₹54.59 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vineet Laboratories Ltd is a below average quality company.

The key valuation ratios of Vineet Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vineet Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Vineet Laboratories Ltd

Vineet Laboratories Limited (Formerly Known As Ortin Laboratories Limited, Unit-II) is public company domiciled in India and incorporated under the provisions of Companies Act, 2013 applicable in India and it was incorporated in India on November 10, 2016 having its Registered office at Saheb Nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam, L B Nagar, Hyderabad, Telangana. The shares of the company are listed on Bombay Stock Exchange and National Stock Exchange.

Business area of the company

The company is engaged in the business of Drug Intermediates & Bulk Dugs.

Product and services

  • API Intermediates
  • Fine Chemicals and Reagents
  • Research & Development
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×